More articles from Poster Presentations - Physicians/Scientists/Pharmacists

You have access
Bioconjugated radioactive gold nanoparticles and their in vivo targeting abilities in small animal models
Raghuraman Kannan, Cutler Cathy, Rahing Valerie, Smith Charles and Kattesh Katti

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 510P;
You have access
The utility of PET/CT imaging of head and neck cancer performed early after surgical resection and prior to adjuvant radiation therapy
Stephanie Shintani, Val Lowe, Paul Brown, Yolanda Garces, Jan Kasperbauer and Robert Foote

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 467P;
You have access
Complete metabolic response following the first cycle of chemotherapy predicts disease-free interval in patients with non-Hodgkin's lymphoma evaluated by serial PET and CT scanning
Hani Nabi, Mohei Abouzied, Edward Bednarczyk, Deborah Erb, Scott Wisniewski, Ellana Eberhardt, Pamela Anderson and John Baker

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 482P;
You have access
Yttrium-90-labeled ibritumomab tiuxetan (Zevalin®) for primary CNS lymphoma
Sofiane Maza, Phillip Kiewe, Kristoph Jahnke, Nancy Doolittle, Agnieszka Korfel, Eckhard Thiel and Dieter Munz

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 484P;
You have access
Bone marrow tolerance to high activities of Rhenium 186 HEDP
Victor McCready, Joe O'Sullivan, Andy Norman, Glenn Flux, Jennie Treleaven and David Dearnaley

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 487P;
You have access
Safety and efficacy evaluation of Y-90 microsphere treatment of liver malignancies using medical internal radiation dosimetry (MIRD)
Seza Gulec, Geraldine Mesoloras, Andrew Dezarn, Patrick McNeal and Andrew Kennedy

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 493P;
You have access
¹⁸F-Labeled analogs of nisoxetine as PET imaging agents for norepinephrine transporters
Vivien Nguyen, Rama Pichika, Balu Easwaramoorthy, Daphne Collins and Jogeshwar Mukherjee

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 497P;
You have access
Delayed F-18 FDG uptake in PET distinguishes between TB and malignant lung lesion: Determination of the optimal cut-off level using ROC analysis
Sungeun Kim, H Jeong, S Lee, C Shin, J Shim, K Kim, J Choe, G Inn, G Kang and S Ryu

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 471P;
You have access
Comparison of quantitative metabolic parameters of measurable tumors for the prediction of treatment response in patients with lymphoma using FDG PET
Byung Hyun Byun, Gi Jeong Cheon, Yeon Hee Park, Sang Woo Lee and Chang Woon Choi

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 482P;
You have access
Synthesis of 18F-labelled cyclooxygenase-2 (COX-2) inhibitor as a potential PET imaging agent
Haibin Tian and Zhenghong Lee

Journal of Nuclear Medicine May 1, 2006, 47 (suppl 1) 506P;

Main menu

User menu

Search

More articles from Poster Presentations - Physicians/Scientists/Pharmacists

Pages